Skip to main content
    I

    Intellia Therapeutics Inc (NTLA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $9.78
    -0.08 (-0.81%)

    Market Cap: $1.36B

    Last updated: Nov 17, 2026 at 4:41 PM ET

    Intellia Therapeutics Inc (NTLA) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Intellia Therapeutics (NTLA) has a latest price of $9.78 on Nov 17, 2026, 47.1% below its 52-week high of $18.48. Its price rose 12.4% over the past 12 months. The month-end price fell 9.5% over the 10 years through Oct 2026, a compound annual decline of 1.0%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $161.91 in Jun 2021 and its lowest $6.87 in May 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart NTLA with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NTLA.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 26.4%, and over 6 months it fell 18.1%. The month-end price fell 50.2% over the 3 years through Oct 2026, a compound annual decline of 20.7%.

    PeriodChange
    1 month-15.5%
    3 months-26.4%
    6 months-18.1%
    12 months+12.4%
    12 months, with dividends+12.4%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-50.2%-20.7%
    5 years-90.6%-37.7%
    10 years-9.5%-1.0%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 270.8%, and its weakest was 2022, when it fell 70.5%.

    YearCloseChange
    2026 through Oct 2026$12.47+38.7%
    2025$8.99-22.9%
    2024$11.66-61.8%
    2023$30.49-12.6%
    2022$34.89-70.5%
    2021$118.24+117.4%
    2020$54.40+270.8%
    2019$14.67+7.5%
    2018$13.65-29.0%
    2017$19.22+46.6%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 17.1% below its 50-day average of $11.80 and 24.3% below its 200-day average of $12.92.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$9.78
    52-week high$18.48-47.1%
    52-week low$7.95+23.0%
    50-day average$11.80-17.1%
    200-day average$12.92-24.3%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 80.9%.

    MeasureValue
    1-year beta2.32
    Largest fall, 1 year-45.6%
    Largest fall, 3 years-80.9%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About NTLA

    What is NTLA's 1-year price change?

    Intellia Therapeutics's price rose 12.4% over the past 12 months. With dividends included, the 12-month total return was 12.4%.

    What is NTLA's 5-year price change?

    Intellia Therapeutics's month-end price fell 90.6% over the 5 years through Oct 2026, a compound annual decline of 37.7%. These figures leave out dividends.

    What is NTLA's 52-week high and low?

    Intellia Therapeutics's 52-week high is $18.48 and its 52-week low is $7.95. Its latest price of $9.78 on Nov 17, 2026 is 47.1% below the high.

    What is NTLA's beta?

    Intellia Therapeutics's 1-year beta against the S&P 500 is 2.32, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 45.6%.

    Is the NTLA chart free?

    Yes. Advanced Charting for NTLA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.